StocksRunner logo
mail
search
 
menu
 
Merck Company
$87.69
+0.56%
 
  Create Alerts  
  
  Overview  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
  
  Headlines  
 

MRK Stock Analysis & IQ Rating | Merck Company

 
 
 

MRK

 

Merck Company

$87.69

 
+$0.49 | +0.56%
 
  Create Alerts  
  
  Overview  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
  
  Headlines  
 
 
52W High
$ 106.49
 
 
MKT CAP
$ 219.04B
 
52W Low
$ 73.31
 
 
VOL
$ 1.30M
 
P/E Ratio
13.52
 
 
AVG VOL
$ 12.54M
 
RSI
59.47
 
 
TREND
Uptrend
 
 
 

MRK Stock IQ

 
lock  Login to see Merck Company (MRK) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

MRK Target Price

 
 
 

Strengths

 

MRK Rewards

 Earnings are forecast to grow

MRK Rewards

 Trading below its fair value

MRK Rewards

 Upgraded on attractively valued

 

Risk Analysis

 

MRK Risk Analysis

 Investors losing their confidence

 
 

Chart

 
 

$78.56   (+11.62%)

$80.17   (+9.38%)

$77.14   (+13.68%)

$100.73   (-12.95%)

 
 
1year
6month
3month
1month
 

MRK Risk Level

 

MRK has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

 
 
 
MRK Risk Level
LOW
HIGH
 

MRK Analysts Opinion

 

MRK overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

 

MRK Earnings Sentiment

 Above analyst estimates

 
 

Rating

×
 

Rating

 

MRK Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 

MRK Momentum Analysis

 Has been gaining momentum

 

Activity

×
 

Activity

 

MRK Activity Sentiment

 Investors losing their confidence

 

Future

×
 

Future

 

MRK Future Sentiment

 Earnings are forecast to grow

MRK Future Sentiment

 Trading below its fair value

 
 

MRK Analysts Opinion

MRK Analysts opinion is positive but there was a setback from the past 3 months

 

MRK Street Consensus

 

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
51%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
50%
40%
48%
 

MRK Street Opinion 

MRK Street view is bullish and have positive views on the near-term outlook

 

MRK Performance Sentiment

 
Sentiments overview associated with MRK events and the stock performance.
 
51%
12%
Positive
Negative
21 out of 41
events present
5 out of 41
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 

Technical Price Levels

 

Average key support and resistance price levels.

 
lock  Login to display
 
Support
Price
 
$87.09
 
Resistance
Price
 
$77.60
 
 
Current Price Range
 
$90.13
 
 
Show methods +
 
 
 
Linked to MRK
IQ
Close Price
Change

 

NVS

4.26

130.80

-0.60%

 

AZN

4.18

82.96

-0.53%

 

PFE

4.09

24.72

+0.14%

 

SNY

3.81

51.43

+3.84%

 

LLY

4.20

829.71

+0.91%

 
 
 
MRK Latest Analysis +
 
 
FAQ About MRK Stock Insights
 

What is MRK current stock price?

What are MRK stock strengths?

What risks are associated with MRK stock?

When is MRK next earnings report?

What is MRK market cap and volume?

What is MRK's current Stock IQ?

Should I buy MRK stock right now?

Is MRK a Strong Buy right now?

What does a 'Strong Buy' rating mean for MRK?

What does a 'Strong Sell' rating mean for MRK?

What factors influence MRK's Stock IQ?

 
 
StocksRunner

Explore our MRK Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored MRK Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our MRK Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
StocksRunner
 
 
StocksRunner Overview
 
StocksRunner Trending
 
StocksRunner Screener
 
StocksRunner Insights
 
StocksRunner Top Rated
 
StocksRunner Momentum
 
StocksRunner Earnings
 
StocksRunner Leaders
mail
 
 

MRK

 

Merck Company

 
 

Current Price

 

$87.69

 
+$0.49 | +0.56%
 
 
52W High
$ 106.49
 
 
MKT CAP
$ 219.04B
 
52W Low
$ 73.31
 
 
VOL
$ 1.30M
 
P/E Ratio
13.52
 
 
AVG VOL
$ 12.54M
 
RSI
59.47
 
 
TREND
Uptrend
 
 
 
  Create Alerts  
  
  Overview  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
 
 
 
 

Target Price

 
 
 
 
Not Enough Information
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 

MRK Rewards

 Earnings are forecast to grow

MRK Rewards

 Trading below its fair value

MRK Rewards

 Upgraded on attractively valued

 

Risk Analysis

 

MRK Risk Analysis

 Investors losing their confidence

 
 
 
 
 

MRK Stock IQ

 
lock  Login to unlock Merck Company (MRK) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 

Chart

 
 

$78.56   (+11.62%)

$80.17   (+9.38%)

$77.14   (+13.68%)

$100.73   (-12.95%)

 
 
1year
6month
3month
1month
 

MRK Analysts Opinion

 

MRK Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

 

MRK Earnings Sentiment

 Above analyst estimates

 
 

Rating

×
 

Rating

 

MRK Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 

MRK Momentum Sentiment

 Has been gaining momentum

 

Activity

×
 

Activity

 

MRK Activity Sentiment

 Investors losing their confidence

 

Future

×
 

Future

 

MRK Future Sentiment

 Earnings are forecast to grow

MRK Future Sentiment

 Trading below its fair value

 
 

MRK Analysts Opinion

MRK Analysts opinion is positive but there was a setback from the past 3 months

 

MRK Street Consensus

 

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
51%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
50%
40%
48%
 

MRK Street Opinion 

MRK Street view is bullish and have positive views on the near-term outlook

 

MRK Risk Level

 

MRK has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

 
 
 
MRK Risk Level
LOW
HIGH
 
MRK Performance Sentiment
 
Sentiments overview associated with MRK events and the stock performance.
 
51%
12%
Positive
Negative
21 out of 41
events present
5 out of 41
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

Technical Price Levels

 

Average key support and resistance price levels.

 
lock  Login to display
 
Support
Price
 
$87.09
 
Resistance
Price
 
$77.60
 
 
Current Price Range
 
$90.13
 
 
Show methods +
 
 
 
 
 
 
 

MRK Latest Analysis

 
 
 

Hidradenitis Suppurativa Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 24 Companies and 26 Therapies | DelveInsight. Hidradenitis Suppurativa Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 24 Companies and 26 Therapies |. DelveInsightThe hidradenitis suppurativa market is poised for strong growth driven by increasing disease awareness earlier diagnosis and expanding treatment access. Advances in biologic and targeted therapies particularly the emergen

 

Thu Oct 23, 2025

$87.18 | -0.55%
 
Activity

Merck (MRK) Earnings Expected to Grow: What to Know Ahead of Next Weeks Release. Merck (MRK) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

 

Thu Oct 23, 2025

$87.18 | -0.55%
 
Earnings
Potential

Guru Fundamental Report for MRK - Peter Lynch. Below is Valideas guru fundamental report for MERCK &. CO INC (MRK). Of the 22 guru strategies we follow MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati

 

Thu Oct 23, 2025

$87.18 | -0.55%
 
Potential

FDA Grants Priority Review For Mercks KEYTRUDA And KEYTRUDA QLEX SBLAs In MIBC . (RTTNews) - Merck & Co Inc. (MRK) on Thursday said that the United States Food and Drug Administration (FDA) has granted priority review for two supplemental Biologics License Applications (sBLA) for KEYTRUDA (pembrolizumab) and KEYTRUDA QLEX (pembrolizumab and berahyaluronidase alfa-pmph

 

Thu Oct 23, 2025

$87.18 | -0.55%
 
Activity

MRK Quantitative Stock Analysis - Peter Lynch. Below is Valideas guru fundamental report for MERCK &. CO INC (MRK). Of the 22 guru strategies we follow MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati

 

Tue Oct 21, 2025

$87.62 | +1.54%
 
Potential

Peter Lynch Detailed Fundamental Analysis - MRK. Below is Valideas guru fundamental report for MERCK &. CO INC (MRK). Of the 22 guru strategies we follow MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati

 

Mon Oct 20, 2025

$86.32 | +1.80%
 
Potential

Will Declining Gardasil Sales Ail MRKs Top Line in Q3 Earnings?. Merck faces a sharp Gardasil slowdown as weak demand in China and Japan affects sales of the vaccine.

 

Fri Oct 17, 2025

$84.79 | +1.04%
 
Activity

Invo Fertility Stock Is Plunging After White House Announcement. ) shares are trading lower on Thursday as investors book profits following White House announcements aimed at making fertility treatments .) to dramatically cut the cost of IVF medications. Under the agreement Merck'.s fertility drugs — like Gonal-f Ovidrel and Cetrotide — will be heavily discounted when used for IVF treatment saving patients approximately $2200 per treatment cycle.In return for the price reductions Merck will

 

Fri Oct 17, 2025

$84.79 | +1.04%
 
Momentum
Potential

Peter Lynch Detailed Fundamental Analysis - MRK. Below is Valideas guru fundamental report for MERCK &. CO INC (MRK). Of the 22 guru strategies we follow MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati

 

Fri Oct 17, 2025

$84.79 | +1.04%
 
Potential

Bank of America Securities Reduces PT on Merck & Co. Inc. (MRK) Keeps a Buy Rating.

 

Fri Oct 17, 2025

$84.79 | +1.04%
 
Rating

 
 
 
 
 
StocksRunner

Discover MRK Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of MRK. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our MRK Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

MRK Stock trends

MRK Stock performance

MRK Stock analysis

MRK investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

MRK Runner Alarm

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 

 
 
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing MRK

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

 
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing MRK

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.